Insilico Medicine Unveils Innovative CDK12/13 Dual Inhibitors for Tumor Therapy with the Help of Generative AI
Insilico Medicine, a pioneering force in the realm of artificial intelligence-driven biotechnology, has made significant strides in the battle against ...
